As of 2025-07-15, the Relative Valuation of Arcutis Biotherapeutics Inc (ARQT) is (23.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.90 USD, the upside of Arcutis Biotherapeutics Inc based on Relative Valuation is -249.5%.
The range of the Relative Valuation is (15.45) - (29.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 26.9x | 20.3x |
| Forward P/E multiples | 14.2x - 32.6x | 23.4x |
| Fair Price | (15.45) - (29.27) | (23.78) |
| Upside | -197.2% - -284.1% | -249.5% |
| Date | P/E |
| 2025-07-11 | -13.79 |
| 2025-07-10 | -14.03 |
| 2025-07-09 | -13.07 |
| 2025-07-08 | -12.64 |
| 2025-07-07 | -12.30 |
| 2025-07-03 | -12.70 |
| 2025-07-02 | -12.64 |
| 2025-07-01 | -12.64 |
| 2025-06-30 | -12.88 |
| 2025-06-27 | -12.63 |
| 2025-06-26 | -13.23 |
| 2025-06-25 | -13.30 |
| 2025-06-24 | -13.17 |
| 2025-06-23 | -13.23 |
| 2025-06-20 | -12.70 |
| 2025-06-18 | -12.56 |
| 2025-06-17 | -12.18 |
| 2025-06-16 | -12.31 |
| 2025-06-13 | -12.34 |
| 2025-06-12 | -12.41 |
| 2025-06-11 | -12.62 |
| 2025-06-10 | -12.76 |
| 2025-06-09 | -13.06 |
| 2025-06-06 | -13.20 |
| 2025-06-05 | -12.41 |
| 2025-06-04 | -12.19 |
| 2025-06-03 | -12.19 |
| 2025-06-02 | -12.39 |
| 2025-05-30 | -11.98 |
| 2025-05-29 | -12.56 |
| 2025-05-28 | -12.48 |
| 2025-05-27 | -12.99 |
| 2025-05-23 | -12.85 |
| 2025-05-22 | -12.55 |
| 2025-05-21 | -12.64 |
| 2025-05-20 | -13.33 |
| 2025-05-19 | -13.45 |
| 2025-05-16 | -12.97 |
| 2025-05-15 | -12.52 |
| 2025-05-14 | -12.50 |
| 2025-05-13 | -12.70 |
| 2025-05-12 | -13.22 |
| 2025-05-09 | -12.43 |
| 2025-05-08 | -12.42 |
| 2025-05-07 | -12.59 |
| 2025-05-06 | -13.16 |
| 2025-05-05 | -14.16 |
| 2025-05-02 | -14.00 |
| 2025-05-01 | -13.46 |
| 2025-04-30 | -13.70 |